HIV Citation List: June 10, 2011- June 23, 2011

Pubmed citations

1. The TRIM Family Protein KAP1 Inhibits HIV-1 Integration. Allouch, A., C. Di Primio, E. Alpi, M. Lusic, D. Arosio, M. Giacca, and A. Cereseto. Cell Host & Microbe, 2011. 9(6): p. 484-495; PMID[21669397].

[PubMed]. HIV_0610-062311.

2. Activation of CB2 Cannabinoid Receptors Inhibits HIV-1 Envelope Glycoprotein gp120-Induced Synapse Loss. Kim, H.J., A.H. Shin, and S.A. Thayer. Molecular Pharmacology, 2011. [Epub ahead of print]; PMID[21670103].

[PubMed]. HIV_0610-062311.

3. Synthesis and Antiviral Activity of Highly Water-soluble Polycarboxylic Derivatives of [70]Fullerene. Kornev, A.B., A.S. Peregudov, V.M. Martynenko, J. Balzarini, B. Hoorelbeke, and P.A. Troshin. Chemical Communications (Cambridge, England), 2011. [Epub ahead of print]; PMID[21666897].

[PubMed]. HIV_0610-062311.

4. Approach toward the Design and Synthesis of Betulinic Acid-Polyphenol Conjugates as Inhibitors of the HIV-1 gp41 Fusion Core Formation. Liu, Y., Z. Ke, K.Y. Wu, S. Liu, W.H. Chen, S. Jiang, and Z.H. Jiang, An Amphiphilic Conjugate ChemMedChem, 2011. [Epub ahead of print]; PMID[21688394].

[PubMed]. HIV_0610-062311.

5. Protein Kinase C (PKC) Theta ({theta}) is a Specific Target for the Inhibition of the Human Immunodeficiency Virus Type 1 (HIV-1) Replication in CD4+ T Lymphocytes. Lopez-Huertas, M.R., E. Mateos, G. Diaz-Gil, F. Gomez-Esquer, M. Sanchez Del Cojo, J. Alcami, and M. Coiras. The Journal of Biological Chemistry, 2011. [Epub ahead of print]; PMID[21669868].

[PubMed]. HIV_0610-062311.

6. A Novel Chimeric Protein-based HIV-1 Fusion Inhibitor Targeting GP41 with High Potency and Stability. Pan, C., L. Cai, H. Lu, L. Lu, and S. Jiang. The Journal of Biological Chemistry, 2011. [Epub ahead of print]; PMID[21690094].

[PubMed]. HIV_0610-062311.

7. Synthesis of Aminoglycoside-3'-Conjugates of 2'-O-Methyl Oligoribonucleotides and Their Invasion to a 19F labelled HIV-1 TAR Model. Virta, P. and A. Kiviniemi. Bioconjugate Chemistry, 2011. [Epub ahead of print]; PMID[21688836].

[PubMed]. HIV_0610-062311.

8. Differential Effect of CLK SR Kinases on HIV-1 Gene Expression: Potential Novel Targets for Therapy. Wong, R., A. Balachandran, A.Y. Mao, W. Dobson, S. Gray-Owen, and A. Cochrane. Retrovirology, 2011. 8(1): p. 47; PMID[21682887].

[PubMed]. HIV_0610-062311.

9. Evolution of Cyclic Peptide Protease Inhibitors. Young, T.S., D.D. Young, I. Ahmad, J.M. Louis, S.J. Benkovic, and P.G. Schultz. Proceedings of the National Academy of Sciences of the United States of America, 2011. [Epub ahead of print]; PMID[21690365].

[PubMed]. HIV_0610-062311.

ISI Web of Knowledge citations

10. Synthesis and Anti-HIV Activity of D-peptide Analogs as HIV Fusion Inhibitors. Baron, A., C. Kreuz, G. Gosselin, F. Lamaty, J. Martinez, D. Surleraux, C. Pierra, and P. Clayette. Antiviral Research, 2011. 90(2): p. A28-A29; ISI[000291182500023].

[WOS]. HIV_0610-062311.

11. Activity of Novel Cyclophilin Inhibitors Based on the Polyketide Sanglifehrin A, against HIV. Bobardt, M., S. Moss, U. Chatterji, M. Nur-E-Alam, T. Warneck, B. Wilkinson, P. Gallay, and M. Gregory. Antiviral Research, 2011. 90(2): p. A29-A29; ISI[000291182500024].

[WOS]. HIV_0610-062311.

12. Carbonylation of Functionalized Diamine Diols to Cyclic Ureas: Application to Derivatives of DMP 450. Darko, A.K., F. Curran, C. Copin, and L. McElwee-White. Tetrahedron, 2011. 67(22): p. 3976-3983; ISI[000291140100002].

[WOS]. HIV_0610-062311.

13. Inhibition of Multi-drug Resistant HIV-1 Reverse Transcriptase by Nucleoside beta-Triphosphates. Dash, C., Y. Ahmadibeni, M. Hanley, J. Pandhare, M. Gotte, S. Le Grice, and K. Parang, Bioorganic & Medicinal Chemistry Letters, 2011. 21(12): p. 3519-3522; ISI[000291145900003].

[WOS]. HIV_0610-062311.

14. Identification of HIV-1 Reverse Transcriptase Dual Inhibitors by a Combined Shape-, 2D-Fingerprint- and Pharmacophore-based Virtual Screening Approach. Distinto, S., F. Esposito, J. Kirchmair, C. Cardia, E. Maccioni, S. Alcaro, L. Zinzula, and E. Tramontano. Antiviral Research, 2011. 90(2): p. A31-A31; ISI[000291182500032].

[WOS]. HIV_0610-062311.

15. Use of Minocycline in Viral Infections. Dutta, K. and A. Basu. Indian Journal of Medical Research, 2011. 133(5): p. 467-470; ISI[000291324400005].

[WOS]. HIV_0610-062311.

16. Design and Synthesis of New Isatin Derivatives as HIV-1 Reverse Transcriptase Associated Ribonuclease H Inhibitors.Esposito, F., R. Meleddu, M. Sanna, S. Distinto, A. Corona, V. Cannas, E. Tramontano, and M. Cardia. Antiviral Research, 2011. 90(2): p. A32-A32; ISI[000291182500035].

[WOS]. HIV_0610-062311.

17. Design and Synthesis of Potent HIV-1 Protease Inhibitors Incorporating Hydroxyprolinamides as Novel P2 Ligands. Gao, B.L., C. Zhang, Y. Yin, L. Tang, and Z. Liu. Bioorganic & Medicinal Chemistry Letters, 2011. 21(12): p. 3730-3733; ISI[000291145900046].

[WOS]. HIV_0610-062311.

18. In silico Screening of Compounds Targeting Human Cyclin T1 and In vitro Evaluation of their Anti-HIV-1 Activity. Hamasaki, T., M. Okamoto, and M. Baba. Antiviral Research, 2011. 90(2): p. A33-A33; ISI[000291182500036].

[WOS]. HIV_0610-062311.

19. The Design and Synthesis of Pyrolle-Carbaldehydes as HIV-1 Integrase Strand-Transfer Inhibitors. Hewer, R., T. Traut, B. Williams, and J. Coates. Antiviral Research, 2011. 90(2): p. A50-A50; ISI[000291182500086].

[WOS]. HIV_0610-062311.

20. Novel 2-Styryl-8-hydroxyquinolines (8SQs) Derivatives with Anti-HIV-1 Activity Targeting Viral Integrase and Protease. Hinkov, A.V., K. Stanoeva, S. Raleva, V. Atanasov, P. Genova-Kalou, and R. Argirova, Antiviral Research, 2011. 90(2): p. A33-A33; ISI[000291182500037].

[WOS]. HIV_0610-062311.

21. Synthesis and Antiproliferative Evaluation of 23-Hydroxybetulinic acid Derivatives. Lan, P., J. Wang, D. Zhang, C. Shu, H. Cao, P. Sun, X. Wu, W. Ye, and W. Chen. European Journal of Medicinal Chemistry, 2011. 46(6): p. 2490-2502; ISI[000291118600059].

[WOS]. HIV_0610-062311.

22. Study of the Efficacy of Combination Therapy of SiRNAs in HepG2.2.15 Cells. Li, G.Q., D. Yu, J. Lu, S. Chen, J. Zhao, and Y. Wang. Hepato-Gastroenterology, 2011. 58(106): p. 570-574; ISI[000291084600055].

[WOS]. HIV_0610-062311.

23. Structural Basis for Drug and Substrate Specificity Exhibited by FIV Encoding a Chimeric FIV/HIV Protease. Lin, Y.C., A. Perryman, A. Olson, B. Torbett, J. Elder, and C. Stout. Acta Crystallographica Section D-Biological Crystallography, 2011. 67: p. 540-548; ISI[000291212900006].

[WOS]. HIV_0610-062311.

24. Synthesis and Some Properties of 4 '-Phenyl-5 '-Norcarbocyclic Adenosine Phosphonic Acid Analogues. Liu, L.J., E. Kim, and J. Hong. Bulletin of the Korean Chemical Society, 2011. 32(5): p. 1662-1668; ISI[000291171000042].

[WOS]. HIV_0610-062311.

25. A Novel Family of Multivalent Compounds able to Interact with GP120 Anti-HIV Evaluation and Binding Analysis With Surface Plasmon Resonance. Lozano, V., L. Aguado, B. Hoorelbeke, M. Renders, M. Camarasa, A. San-Felix, J. Balzarini, and M. Perez-Perez. Antiviral Research, 2011. 90(2): p. A72-A72; ISI[000291182500148].

[WOS]. HIV_0610-062311.

26. Polarity Changes in the Transmembrane Domain Core of HIV-1 Vpu Inhibits Its Anti-Tetherin Activity. Lv, M.Y., J. Wang, X. Wang, T. Zuo, Y. Zhu, W. Kong, and X. Yu. Plos One, 2011. 6(6); ISI[000291310600035].

[WOS]. HIV_0610-062311.

27. Effect of Methamphetamine on Expression of HIV Coreceptors and CC-chemokines by Dendritic Cells. Nair, M.P.N. and Z. Saiyed. Life Sciences, 2011. 88(21-22): p. 987-994; ISI[000291144100012].

[WOS]. HIV_0610-062311.

28. Long-term Inhibition of HIV-1 Replication in CD4(+) T Cells Transduced with a Retroviral Vector Conditionally Expressing the Escherichia coli Endoribonuclease MazF. Okamoto, M., H. Chono, H. Tsuda, K. Inoue, J. Mineno, and M. Baba. Antiviral Research, 2011. 90(2): p. A38-A38; ISI[000291182500052].

[WOS]. HIV_0610-062311.

29. Synthesis, Anti-HIV and Cytotoxic Activity of Some Novel Isatine-Sulfisomidine Derivatives. Selvam, P., M. Chandramohan, C. Pannecouque, and E. De Clercq. Antiviral Research, 2011. 90(2): p. A42-A42; ISI[000291182500064].

[WOS]. HIV_0610-062311.

30. Studies of HIV Integrase Inhibitory Activity of Novel Isatine Derivatives. Selvam, P., K. Maddali, C. Marchand, and Y. Pommier. Antiviral Research, 2011. 90(2): p. A43-A43; ISI[000291182500065].

[WOS]. HIV_0610-062311.

31. Simultaneous Determination of Antiretroviral Zidovudine, Lamivudine and Efavirenz by RP HPLC-DAD. Soares, M., J. Soares-Sobrinho, K. da Silva, L. Rolim, L. Alves, and P. Rolim-Neto. Latin American Journal of Pharmacy, 2011. 30(2): p. 273-280; ISI[000291136700009].

[WOS]. HIV_0610-062311.

32. Services for Prediction of Drug Susceptibility for HIV Proteases and Reverse Transcriptases at the HIV Drug Research Centre. Spjuth, O., M. Eklund, M. Lapins, M. Junaid, and J. Wikberg, Bioinformatics, 2011. 27(12): p. 1719-1720; ISI[000291261300027].

[WOS]. HIV_0610-062311.

33. Polymer-coupled Systems for Blocking the Viral Fusion 1. Modeling in silico the in vitro HIV-1 Entry Inhibitors. Tsvetkov, V., A. Veselovski, and A. Serbin. Antiviral Research, 2011. 90(2): p. A46-A46; ISI[000291182500074].

[WOS]. HIV_0610-062311.

34. Synthesis and Antiviral Activity of 3-Methoxy-2-(phosphonomethoxy)propyl Nucleoside Esters Against HCV and HIV-1. Valiaeva, N., J. Beadle, D. Wyles, R. Schooley, and K. Hostetler. Antiviral Research, 2011. 90(2): p. A77-A77; ISI[000291182500163].

[WOS]. HIV_0610-062311.

35. Novel Inhibitors of Nuclear Translocation of HIV-1 Integrase. Wagstaff, K., S. Rawlinson, A. Hearps, and D. Jans. Antiviral Research, 2011. 90(2): p. A48-A48; ISI[000291182500080].

[WOS]. HIV_0610-062311.

36. Isolation and Characterization of a Novel Thermostable Lectin from the Wild Edible Mushroom Agaricus arvensis. Zhao, J.K., Y. Zhao, S. Li, H. Wang, and T. Ng, Journal of Basic Microbiology, 2011. 51(3): p. 304-311; ISI[000291107500009].

[WOS]. HIV_0610-062311.